Is a complete VTVT research report available?

No complete published report is available for vTv Therapeutics Inc. (VTVT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

vTv Therapeutics Inc. (VTVT)

NASDAQ: VTVT · USD

$25.3

-0.42 (-1.6%)· Recorded snapshot

Market cap	314.3M
Revenue (ttm)	36.8M
Net income (ttm)	-4.8M
EPS (ttm)	-$0.42
Shares out	12.4M
Volume	16,262
Beta	0.21

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 36.8M
Net income (ttm): -4.8M
EPS (ttm): -$0.42
Market cap: 314.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Metric	Value
Amount currency	USD
CIK code	0001641489
Company name	vTv Therapeutics Inc.
Country	United States
Country code	US
CUSIP number	918385204
Earnings date	2026-11-09
Earnings time	amc
Employees	26
Employees change	3
Employees growth	13.04%
Enterprise value	$227.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Biotechnology
IPO date	2015-07-30
Is primary listing	Yes
Is SPAC	No
ISIN number	US9183852048
Last 10-K release date	2026-03-10
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2023-11-21
Last stock split type	Reverse
Market cap	$314.3M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	No
Price	$25.30
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	VTVT
U.S. state	North Carolina
Website	https://vtvtherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001641489

Company name

vTv Therapeutics Inc.

Country

United States

Country code

CUSIP number

918385204

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

Employees growth

13.04%

Enterprise value

$227.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

Industry

Biotechnology

IPO date

2015-07-30

Is primary listing

Yes

Is SPAC

ISIN number

US9183852048

Last 10-K release date

2026-03-10

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2023-11-21

Last stock split type

Reverse

Market cap

$314.3M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Price

$25.30

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

VTVT

U.S. state

North Carolina

Website

https://vtvtherapeutics.com

Metric	Value
Earnings yield	-1.67%
EV/Sales	6.32x
FCF / EV yield	-7.2%
FCF yield	-5.25%
P/B ratio	4.06x
P/S ratio	8.67x
Price / tangible book value	4.06x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-1.67%

EV/Sales

6.32x

FCF / EV yield

-7.2%

FCF yield

-5.25%

P/B ratio

4.06x

P/S ratio

8.67x

Price / tangible book value

4.06x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-25.11%
EBITDA margin	-25.1%
Gross margin	22.16%
Operating margin	-25.11%
Pretax margin	-17.38%
Profit margin	-12.91%
Profit per employee	$-182,923
Revenue per employee	$1.4M
ROA	-10.14%
ROA (5Y)	-55.13%
ROCE	-11.48%
ROE	-15.8%
ROIC	-14.26%
SBC / revenue	13.97%

Metric

Value

EBIT margin

-25.11%

EBITDA margin

-25.1%

Gross margin

22.16%

Operating margin

-25.11%

Pretax margin

-17.38%

Profit margin

-12.91%

Profit per employee

$-182,923

Revenue per employee

$1.4M

ROA

-10.14%

ROA (5Y)

-55.13%

ROCE

-11.48%

ROE

-15.8%

ROIC

-14.26%

SBC / revenue

13.97%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth	216,600%
Revenue growth 10Y	44.68%
Revenue growth 3Y	1,499.64%
Revenue growth 5Y	37.85%
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth

216,600%

Revenue growth 10Y

44.68%

Revenue growth 3Y

1,499.64%

Revenue growth 5Y

37.85%

Revenue growth years

Metric	Value
Depreciation and amortization	$6,000
EBIT	$-9.3M
EBITDA	$-9.2M
EPS	$-0.42
FCF per share	$-1.35
Financing cash flow	$77.5M
Free cash flow	$-16.8M
Free cash flow minus SBC	$-21.9M
Gross profit	$8.2M
Net cash flow	$60.7M
Net income	$-4.8M
Operating cash flow minus SBC	$-21.9M
Operating income	$-9.3M
Revenue	$36.8M
Stock-based compensation	$5.1M

Metric

Value

Depreciation and amortization

$6,000

EBIT

$-9.3M

EBITDA

$-9.2M

EPS

$-0.42

FCF per share

$-1.35

Financing cash flow

$77.5M

Free cash flow

$-16.8M

Free cash flow minus SBC

$-21.9M

Gross profit

$8.2M

Net cash flow

$60.7M

Net income

$-4.8M

Operating cash flow minus SBC

$-21.9M

Operating income

$-9.3M

Revenue

$36.8M

Stock-based compensation

$5.1M

Metric	Value
Altman Z-Score	18.43
Book value per share	$6.34
Debt / equity	0
Interest coverage	-1,541.83
Long-term assets	$4,000
Long-term liabilities	$1.9M
Net cash (debt)	$86.6M
Net cash / market cap	27.13%
Net cash growth	235.27%
Net debt / equity	-1.1
Piotroski F-Score	2
Shareholders' equity	$78.6M
Tangible book value	$78.6M
Tangible book value per share	$6.34
Total assets	$87.6M
Total cash	$86.6M
Total debt	$0
Total liabilities	$9M
WACC	5.39%

Metric

Value

Altman Z-Score

18.43

Book value per share

$6.34

Debt / equity

Interest coverage

-1,541.83

Long-term assets

$4,000

Long-term liabilities

$1.9M

Net cash (debt)

$86.6M

Net cash / market cap

27.13%

Net cash growth

235.27%

Net debt / equity

-1.1

Piotroski F-Score

Shareholders' equity

$78.6M

Tangible book value

$78.6M

Tangible book value per share

$6.34

Total assets

$87.6M

Total cash

$86.6M

Total debt

Total liabilities

$9M

WACC

5.39%

Metric	Value
Asset turnover	0.65
Current assets	$87.6M
Current liabilities	$7M
Current ratio	12.48
Net working capital	$-6.1M
Quick ratio	12.35
Working capital	$80.6M
Working capital turnover	0.72

Metric

Value

Asset turnover

0.65

Current assets

$87.6M

Current liabilities

$7M

Current ratio

12.48

Net working capital

$-6.1M

Quick ratio

12.35

Working capital

$80.6M

Working capital turnover

0.72

Metric	Value
Buyback yield / dilution	-74.02%
Dividend yield	0%
Shareholder yield	-74.02%

Metric

Value

Buyback yield / dilution

-74.02%

Dividend yield

Shareholder yield

-74.02%

Metric	Value
10Y price change	-90.1%
10Y return CAGR	-20.65%
10Y total return	-90.1%
150-day SMA	$32.95
1D price change	-1.63%
1M price change	-16.25%
1M total return	-16.25%
1W price change	-8.89%
1W total return	-8.89%
1Y price change	19.4%
1Y return CAGR	19.41%
1Y total return	19.4%
20-day SMA	$28.37
200-day SMA	$33.63
3M price change	-18.44%
3M total return	-18.44%
3Y price change	46.14%
3Y return CAGR	13.48%
3Y total return	46.14%
50-day SMA	$30.56
50-day SMA vs 200-day SMA	50under200
52-week high	$44.00
52-week high date	2026-01-06
52-week low	$19.80
52-week low date	2025-10-29
5Y price change	-54.5%
5Y return CAGR	-14.57%
5Y total return	-54.5%
6M price change	-13.95%
6M total return	-13.95%
All-time high	$560.00
All-time high date	2015-07-30
All-time low	$7.38
All-time low date	2024-01-26
Average true range (ATR)	$1.32
Average volume	21K
Beta (1Y)	-0.58
Beta (2Y)	0.49
Beta (5Y)	0.21
Change from 52-week high	-42.5%
Change from 52-week low	27.78%
Change from all-time high	-95.48%
Change from all-time low	242.82%
Change from open	-1.44%
Day's gap	-0.19%
Dollar volume	$411,429
High price	$25.70
Low price	$25.30
Monthly RSI	47.01
Open price	$25.67
Position in 52-week range	0%
Previous close	$25.72
Price vs 150-day SMA	-23.21%
Price vs 20-day SMA	-10.83%
Price vs 200-day SMA	-24.77%
Price vs 50-day SMA	-17.22%
Relative volume	0.78
RSI	31.16
Sharpe ratio	0.57
Sharpe ratio (3Y)	0.5
Sharpe ratio (5Y)	0.2
Sortino ratio	0.94
Sortino ratio (3Y)	1.03
Sortino ratio (5Y)	0.43
Volume	16.3K
Weekly RSI	37.77
YTD price change	-36.73%
YTD total return	-36.73%

Metric

Value

10Y price change

-90.1%

10Y return CAGR

-20.65%

10Y total return

-90.1%

150-day SMA

$32.95

1D price change

-1.63%

1M price change

-16.25%

1M total return

-16.25%

1W price change

-8.89%

1W total return

-8.89%

1Y price change

19.4%

1Y return CAGR

19.41%

1Y total return

19.4%

20-day SMA

$28.37

200-day SMA

$33.63

3M price change

-18.44%

3M total return

-18.44%

3Y price change

46.14%

3Y return CAGR

13.48%

3Y total return

46.14%

50-day SMA

$30.56

50-day SMA vs 200-day SMA

50under200

52-week high

$44.00

52-week high date

2026-01-06

52-week low

$19.80

52-week low date

2025-10-29

5Y price change

-54.5%

5Y return CAGR

-14.57%

5Y total return

-54.5%

6M price change

-13.95%

6M total return

-13.95%

All-time high

$560.00

All-time high date

2015-07-30

All-time low

$7.38

All-time low date

2024-01-26

Average true range (ATR)

$1.32

Average volume

21K

Beta (1Y)

-0.58

Beta (2Y)

0.49

Beta (5Y)

0.21

Change from 52-week high

-42.5%

Change from 52-week low

27.78%

Change from all-time high

-95.48%

Change from all-time low

242.82%

Change from open

-1.44%

Day's gap

-0.19%

Dollar volume

$411,429

High price

$25.70

Low price

$25.30

Monthly RSI

47.01

Open price

$25.67

Position in 52-week range

Previous close

$25.72

Price vs 150-day SMA

-23.21%

Price vs 20-day SMA

-10.83%

Price vs 200-day SMA

-24.77%

Price vs 50-day SMA

-17.22%

Relative volume

0.78

RSI

31.16

Sharpe ratio

0.57

Sharpe ratio (3Y)

0.5

Sharpe ratio (5Y)

0.2

Sortino ratio

0.94

Sortino ratio (3Y)

1.03

Sortino ratio (5Y)

0.43

Volume

16.3K

Weekly RSI

37.77

YTD price change

-36.73%

YTD total return

-36.73%

Metric	Value
Float	2.2M
Float percentage	17.38%
Shares change (QoQ)	-15.2%
Shares change (YoY)	74.02%
Shares held by insiders	0.36%
Shares held by institutions	15.45%
Shares outstanding	12.4M
Short % of float	6.64%
Short % of shares	1.15%
Short ratio	3.7 days

Metric

Value

Float

2.2M

Float percentage

17.38%

Shares change (QoQ)

-15.2%

Shares change (YoY)

74.02%

Shares held by insiders

0.36%

Shares held by institutions

15.45%

Shares outstanding

12.4M

Short % of float

6.64%

Short % of shares

1.15%

Short ratio

3.7 days

vTv Therapeutics Inc. (VTVT)

Price

Financial snapshot

Fair-value bridge

Latest news · VTVT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VTVT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VTVT

Frequently asked questions